2-(Tributylstannyl)-1,3-thiazole → HCID 57634240, compound

HRID 2109453Notes

Reaction equation

HRID 2109453 reaction equation
Br[C:2]1[O:6][C:5]([N:7]2[CH2:11][C@:10]3([CH:16]4[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]4)[CH2:12]3)[O:9][C:8]2=[O:19])=[CH:4][CH:3]=1.C([Sn](CCCC)(CCCC)[C:25]1[S:26][CH:27]=[CH:28][N:29]=1)CCC>>[S:26]1[CH:27]=[CH:28][N:29]=[C:25]1[C:2]1[O:6][C:5]([N:7]2[CH2:11][C@:10]3([CH:16]4[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]4)[CH2:12]3)[O:9][C:8]2=[O:19])=[CH:4][CH:3]=1

Participants

3

Procedure

The title compound was prepared by a method analogous to that described in Example 14 from (R)-3′-(5-bromofuran-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5′-oxazolidin]-2′-one and 2-(tri-n-butylstannyl)thiazole. The title compound (19 mg) was obtained as a pale solid, m/z 332 (MH+).

Workup

  1. customThe title compound was prepared by a method analogous to

Sources & evidence

ORD record
ord-f3bc6be12c7d4db2a813939effc269bb
Source dataset
uspto-grants-2009_04
Patent number
US07514567B2

Reaction notes

Loading…